Global Hospital Care Partnering 2015-2022: Key Deal Trends, Players and Financials

12 Jul 2022
www.prnewswire.com
Antibody
DUBLIN, July 12, 2022 /PRNewswire/ -- The "Global Hospital Care Partnering 2015-2022: Deal Trends, Players and Financials" report has been added to
ResearchAndMarkets.com's offering.
Global Hospital Care Partnering 2015 to 2022 provides the full collection of Hospital Care disease deals signed between the world's pharmaceutical and biotechnology companies since 2015.
Trends in Hospital Care partnering deals
Financial deal terms for headline, upfront and royalty by stage of development
Hospital Care partnering agreement structure
Hospital Care partnering contract documents
Top Hospital Care deals by value
Most active Hospital Care dealmakers
Most of the deals included within the report occur when a licensee obtains a right or an option right to license a licensor's product or technology. More often these days these deals tend to be multi-component including both a collaborative R&D and a commercialization of outcomes element.
The report takes readers through the comprehensive Hospital Care disease deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering Hospital Care deals.
The report presents financial deal terms values for Hospital Care deals, where available listing by overall headline values, upfront payments, milestones and royalties enabling readers to analyse and benchmark the value of current deals.
Global Hospital Care Partnering 2015 to 2022 includes:
Trends in Hospital Care dealmaking in the biopharma industry since 2015
Access to headline, upfront, milestone and royalty data
Access to hundreds of Hospital Care deal contract documents
Comprehensive access to over 1200 Hospital Care deal records
The leading Hospital Care deals by value since 2015
Most active Hospital Care dealmakers since 2015
Key Topics Covered:
Chapter 1 - Introduction
Chapter 2 - Trends in Hospital Care dealmaking
2.1. Introduction
2.2. Hospital Care partnering over the years
2.3. Hospital Care partnering by deal type
2.4. Hospital Care partnering by industry sector
2.5. Hospital Care partnering by stage of development
2.6. Hospital Care partnering by technology type
2.7. Hospital Care partnering by therapeutic indication
Chapter 3 -Financial deal terms for Hospital Care partnering
3.1. Introduction
3.2. Disclosed financials terms for Hospital Care partnering
3.3. Hospital Care partnering headline values
3.4. Hospital Care deal upfront payments
3.5. Hospital Care deal milestone payments
3.6. Hospital Care royalty rates
Chapter 4 - Leading Hospital Care deals and dealmakers
4.1. Introduction
4.2. Most active in Hospital Care partnering
4.3. List of most active dealmakers in Hospital Care
4.4. Top Hospital Care deals by value
Chapter 5 - Hospital Care contract document directory
5.1. Introduction
5.2. Hospital Care partnering deals where contract document available
Chapter 6 - Hospital Care dealmaking by therapeutic target
6.1. Introduction
6.2. Deals by Hospital Care therapeutic target
Companies Mentioned
3M
3SBio
111
Acare Medical Science
Accelus
AccuTec Blades
Acelity
Acell
Acentrus Specialty
ActLight
AdaptHealth
ADAS 3D Medical
Adeor Medical
Adhezion Biomedical
Advanced Cooling Therapy
Aerapy
Aesthetic Management Partners
Agadia Systems
Agiliti
Aguettant
Aidoc
Aitrics
Algeos
ALK-Abello
Allergan
Allergan Aesthetics
Allied Centre for Medical Excellence
Alliqua Biomedical
Alloksys Life Sciences
Almirall
Alphamedix
Altitude International
Alvarado Hospital Medical Center
Alyzen Medical Physics
Ambra Health
Ambu
Amedisys
American Society for Aesthetic Plastic Surgery
American Well
Amerinet
AMNIOX
Amplifire
Ancestry
Anelto
Angiodynamics
Anita Tecnica
Anthem
Apex Physics Partners
Applied DNA Sciences
Applimotion
APR Medtech
Archer Capital
argenx
Argon Medical Devices
Aridea Solutions
Arkansas Childrens Hospital
Armaghan Salamat Kish
Armor
Artegraft
Arthrex
Asahi Kasei
Ascendum
Ascension
Ascension Saint Thomas
Asensus Surgical
ASICO
Aspen Surgical Products
Assure
Asys
Athersys
Atlas Lift Tech
Atnahs Pharma
Atricure
For more information about this report visit https://www.researchandmarkets.com/r/lcutzo
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Logo: http://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
SOURCE Research and Markets
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-
Drugs
-
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.